Provided by Tiger Trade Technology Pte. Ltd.

Olema Pharmaceuticals, Inc.

9.73
-0.0500-0.51%
Post-market: 9.70-0.0300-0.31%19:42 EDT
Volume:1.25M
Turnover:12.05M
Market Cap:848.04M
PE:-4.57
High:9.93
Open:9.86
Low:9.44
Close:9.78
52wk High:36.26
52wk Low:6.65
Shares:87.16M
Float Shares:71.89M
Volume Ratio:0.95
T/O Rate:1.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1289
EPS(LYR):-1.8700
ROE:-52.74%
ROA:-31.82%
PB:1.97
PE(LYR):-5.20

Loading ...

Olema Adds Deal Veteran Prakash Raman To Guide Oncology Partnerships

Simply Wall St.
·
May 03

Olema Pharmaceuticals Signs New Headquarters Lease at Oyster Point

TIPRANKS
·
May 02

Olema Pharmaceuticals Adds Veteran Director to Support Growth

TIPRANKS
·
Apr 30

Olema Pharmaceuticals announces annual shareholder meeting via webcast

Reuters
·
Apr 30

Olema appoints Prakash Raman to board of directors

Reuters
·
Apr 30

Olema Oncology Appoints Prakash Raman, Ph.d., to Board of Directors

THOMSON REUTERS
·
Apr 30

Press Release: Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors

Dow Jones
·
Apr 30

Olema Pharmaceuticals (OLMA) Valuation Check After New Palazestrant And OP-3136 Preclinical Results

Simply Wall St.
·
Apr 27

Olema Oncology to present initial clinical data for OP-3136 at ASCO

TIPRANKS
·
Apr 22

Olema to present initial Phase 1 OP-3136 clinical data at ASCO meeting

Reuters
·
Apr 22

Olema Pharmaceuticals (OLMA) Is Up 5.6% After Preclinical Data Highlight Deeper ER Blockade Potential

Simply Wall St.
·
Apr 21

A Look At Olema Pharmaceuticals (OLMA) Valuation After New Preclinical Breast Cancer Data

Simply Wall St.
·
Apr 20

Olema Oncology announces preclinical data for Palazestrant

TIPRANKS
·
Apr 18

Olema says OP-3136 Phase 1 trial enrolls patients in breast cancer study

Reuters
·
Apr 18

Olema grants inducement stock options for 188,500 shares to four new employees

Reuters
·
Apr 03

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Apr 03

A Look At Olema Pharmaceuticals (OLMA) Valuation After Earnings And New Shelf Registration Filing

Simply Wall St.
·
Mar 30

Olema Pharmaceuticals Initiated at Peer Perform by Wolfe Research

Dow Jones
·
Mar 27

Olema Oncology initiated with a Peer Perform at Wolfe Research

TIPRANKS
·
Mar 27

LifeSci Capital Reaffirms Their Buy Rating on Olema Pharmaceuticals (OLMA)

TIPRANKS
·
Mar 21